ORAMED PHARMACEUTICALS INC. Shares, Issued
ORAMED PHARMACEUTICALS INC. (ORMP) had Shares, Issued of 18.00 thousand shares as of 2022-01-03, per its 10-K filed 2024-03-06.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:SharesIssued · last filed 2024-03-06
- 2022-01-03: Shares, Issued 18.00K shares.
| Period end | Shares, Issued |
|---|---|
| 2022-01-03 | 18.00K shares 10-K · filed 2024-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |